63 related articles for article (PubMed ID: 7579407)
1. Measurement of whole body interleukin-6 (IL-6) production: prediction of the efficacy of anti-IL-6 treatments.
Lu ZY; Brailly H; Wijdenes J; Bataille R; Rossi JF; Klein B
Blood; 1995 Oct; 86(8):3123-31. PubMed ID: 7579407
[TBL] [Abstract][Full Text] [Related]
2. Exploring Novel Frontiers: Leveraging STAT3 Signaling for Advanced Cancer Therapeutics.
Adesoye T; Tripathy D; Hunt KK; Keyomarsi K
Cancers (Basel); 2024 Jan; 16(3):. PubMed ID: 38339245
[TBL] [Abstract][Full Text] [Related]
3. A simple-to-use nomogram for predicting the risk of radiation pneumonitis in patients with thoracic segment esophageal squamous cell carcinoma.
Qiu T; Deng Y; Guo H; Zhang H
Transl Cancer Res; 2022 Oct; 11(10):3754-3766. PubMed ID: 36388040
[TBL] [Abstract][Full Text] [Related]
4. Optimisation of anti-interleukin-6 therapy: Precision medicine through mathematical modelling.
Rossi JF; Chiang HC; Lu ZY; Levon K; van Rhee F; Kanhai K; Fajgenbaum DC; Klein B
Front Immunol; 2022; 13():919489. PubMed ID: 35928820
[TBL] [Abstract][Full Text] [Related]
5. Beta
Hostrup M; Knudsen JG; Kristensen CM; Jessen S; Pilegaard H; Bangsbo J
Scand J Med Sci Sports; 2022 Jul; 32(7):1099-1108. PubMed ID: 35460295
[TBL] [Abstract][Full Text] [Related]
6. A Novel Humanized Anti-Interleukin-6 Antibody HZ0408b With Anti-Rheumatoid Arthritis Therapeutic Potential.
Liu X; Li L; Wang Q; Jiang F; Zhang P; Guo F; Liu H; Huang J
Front Immunol; 2021; 12():816646. PubMed ID: 35126375
[TBL] [Abstract][Full Text] [Related]
7. A New Approach to the Management of COVID-19. Antagonists of IL-6: Siltuximab.
Villaescusa L; Zaragozá F; Gayo-Abeleira I; Zaragozá C
Adv Ther; 2022 Mar; 39(3):1126-1148. PubMed ID: 35072887
[TBL] [Abstract][Full Text] [Related]
8. IL-6 antagonists to replace systemic corticosteroids as the preferred anti-inflammatory therapy in patients with COVID-19?
Kow CS; Zaihan AF; Ramachandram DS; Hasan SS
Cytokine; 2022 Jan; 149():155730. PubMed ID: 34628129
[No Abstract] [Full Text] [Related]
9. IL-6 in inflammation, autoimmunity and cancer.
Hirano T
Int Immunol; 2021 Mar; 33(3):127-148. PubMed ID: 33337480
[TBL] [Abstract][Full Text] [Related]
10. Translating IL-6 biology into effective treatments.
Choy EH; De Benedetti F; Takeuchi T; Hashizume M; John MR; Kishimoto T
Nat Rev Rheumatol; 2020 Jun; 16(6):335-345. PubMed ID: 32327746
[TBL] [Abstract][Full Text] [Related]
11. Monoclonal Antibodies for the Treatment of Multiple Myeloma: An Update.
Abramson HN
Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30544512
[TBL] [Abstract][Full Text] [Related]
12. A mathematical model of aortic aneurysm formation.
Hao W; Gong S; Wu S; Xu J; Go MR; Friedman A; Zhu D
PLoS One; 2017; 12(2):e0170807. PubMed ID: 28212412
[TBL] [Abstract][Full Text] [Related]
13. Urinary interleukin-6 as a predictor of radiographic progression in rheumatoid arthritis: A 3-year evaluation.
Park YJ; Yoo SA; Kim GR; Cho CS; Kim WU
Sci Rep; 2016 Oct; 6():35242. PubMed ID: 27731382
[TBL] [Abstract][Full Text] [Related]
14. Simultaneous occurrence of Hodgkin's lymphoma and multiple myeloma: A case report and review of the literature.
Huang C; Zhao G; Wang L; Zhang H; Wu X; Zhang M; Ma R; Wang L; Liu Y; Liu L
Oncol Lett; 2016 Jun; 11(6):4139-4143. PubMed ID: 27313755
[TBL] [Abstract][Full Text] [Related]
15. Modeling Granulomas in Response to Infection in the Lung.
Hao W; Schlesinger LS; Friedman A
PLoS One; 2016; 11(3):e0148738. PubMed ID: 26986986
[TBL] [Abstract][Full Text] [Related]
16. Pathogenic Inflammation and Its Therapeutic Targeting in Systemic Lupus Erythematosus.
Gottschalk TA; Tsantikos E; Hibbs ML
Front Immunol; 2015; 6():550. PubMed ID: 26579125
[TBL] [Abstract][Full Text] [Related]
17. Inverse Correlation between Serum C-Reactive Protein and Magnesium Levels in Smokers and Nonsmokers.
Ata MA; Shaikh SS; Iqbal T; Hina ; Jamil D; Khan R; Qazi MB; Riwan T
N Am J Med Sci; 2015 Jun; 7(6):271-4. PubMed ID: 26199924
[TBL] [Abstract][Full Text] [Related]
18. Clinical development of siltuximab.
Davis CC; Shah KS; Lechowicz MJ
Curr Oncol Rep; 2015 Jul; 17(7):29. PubMed ID: 25986720
[TBL] [Abstract][Full Text] [Related]
19. Safety, tolerability, pharmacokinetics and pharmacodynamics of an anti- oncostatin M monoclonal antibody in rheumatoid arthritis: results from phase II randomized, placebo-controlled trials.
Choy EH; Bendit M; McAleer D; Liu F; Feeney M; Brett S; Zamuner S; Campanile A; Toso J
Arthritis Res Ther; 2013 Sep; 15(5):R132. PubMed ID: 24286335
[TBL] [Abstract][Full Text] [Related]
20. Extra-hepatic cancer represses hepatic drug metabolism via interleukin (IL)-6 signalling.
Kacevska M; Mahns A; Sharma R; Clarke SJ; Robertson GR; Liddle C
Pharm Res; 2013 Sep; 30(9):2270-8. PubMed ID: 23604979
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
